As one of insulin sensitizing agents, rosiglitazone is mainly used to cure type 2 diabetes mellitus.

• 国外十余年的临床应用发现，罗格列酮可明显改善2型糖尿病病人的血脂紊乱，延缓动脉粥样硬化病变进展。